医学
贝伐单抗
肿瘤科
卵巢癌
内科学
外科
打开标签
随机对照试验
化疗
癌症
作者
Jacobus Pfisterer,Florence Joly,Gunnar B. Kristensen,Jörn Rau,Sven� Mahner,Patricia Pautier,Ahmed El‐Balat,Jean‐Emmanuel Kurtz,Ulrich Canzler,Jalid Sehouli,Martin Heubner,Andreas D. Hartkopf,Klaus Baumann,Annette Hasenburg,Lars Hanker,Antje Belau,Barbara Schmalfeldt,Dominik Denschlag,Tjoung‐Won Park‐Simon,Frédèric Selle
摘要
Longer treatment duration with bevacizumab for up to 30 months did not improve PFS or OS in patients with primary epithelial ovarian, fallopian tube, or peritoneal cancer. A bevacizumab treatment duration of 15 months remains the standard of care.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
GingerF
OK
fantasy
奋斗易真
Nole
不潮薯饼
Zephyrite
斯文钢笔
Copyright
初景
划子
斯文的初蝶
小小牛马
无极微光
14and15
儒雅的板栗
潇洒的惋清
Zzzz
老胡
皖公网安备34019202002308
